It’s hard even for a healthcare insider to navigate the system, let alone appeal a denial with amorphous reasoning behind it.
Related stories
Stocks are stumbling after Labor Day. Why the easy gains of 2026 may be over.
Why a stronger Japanese currency could spell trouble for AI and technology stocks
Smithsonian head to resign as Trump seeks to reshape institution
Why you shouldn’t stake your entire retirement plan on getting an inheritance
What is causing the global bond sell-off?
Strive Buys $109 Million in Bitcoin, Pushes Preferred Stock Toward $1 Billion